IMPACT OF THE E3 UBIQUITIN LIGASE TRAF2 ON TNF-A-INDUCED APOPTOSIS IN A CELL MODEL OF FLT3-ITD-POSITIVE AML

被引：0
|
作者：
Schnetzke, U. [1 ]
Fischer, M. [1 ]
Spies-Weisshart, B. [1 ]
Mueller, J. [2 ]
Hochhaus, A. [1 ]
Scholl, S. [1 ]
机构：
[1] Univ Hosp, Abt Onkol & Hamatol, Klin Innere Med 2, Jena, Germany
[2] Univ Hosp, Inst Mol Zellbiol, Jena, Germany
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P653
引用
收藏
页码：275 / 276
页数：2
相关论文
共 50 条
  • [1] The E3 ubiquitin ligase TRAF2 can contribute to TNF-α resistance in FLT3-ITD-positive AML cells
    Schnetzke, Ulf
    Fischer, Mike
    Spies-Weisshart, Baerbel
    Zirm, Elisabeth
    Hochhaus, Andreas
    Mueller, Joerg P.
    Scholl, Sebastian
    LEUKEMIA RESEARCH, 2013, 37 (11) : 1557 - 1564
  • [2] The E3 ubiquitin ligase TRAF6 inhibits LPS-induced AKT activation in FLT3-ITD-positive MV4-11 AML cells
    Schnetzke, Ulf
    Fischer, Mike
    Kuhn, Anne-Kathrin
    Spies-Weisshart, Baerbel
    Zirm, Elisabeth
    Hochhaus, Andreas
    Mueller, Joerg P.
    Scholl, Sebastian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (04) : 605 - 615
  • [3] The E3 ubiquitin ligase TRAF6 inhibits LPS-induced AKT activation in FLT3-ITD-positive MV4-11 AML cells
    Ulf Schnetzke
    Mike Fischer
    Anne-Kathrin Kuhn
    Bärbel Spies-Weisshart
    Elisabeth Zirm
    Andreas Hochhaus
    Jörg P. Müller
    Sebastian Scholl
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 605 - 615
  • [4] Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2
    Sergio E. Alvarez
    Kuzhuvelil B. Harikumar
    Nitai C. Hait
    Jeremy Allegood
    Graham M. Strub
    Eugene Y. Kim
    Michael Maceyka
    Hualiang Jiang
    Cheng Luo
    Tomasz Kordula
    Sheldon Milstien
    Sarah Spiegel
    Nature, 2010, 465 : 1084 - 1088
  • [5] Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2
    Alvarez, Sergio E.
    Harikumar, Kuzhuvelil B.
    Hait, Nitai C.
    Allegood, Jeremy
    Strub, Graham M.
    Kim, Eugene Y.
    Maceyka, Michael
    Jiang, Hualiang
    Luo, Cheng
    Kordula, Tomasz
    Milstien, Sheldon
    Spiegel, Sarah
    NATURE, 2010, 465 (7301) : 1084 - U149
  • [6] Midostaurin-induced Sweet syndrome in a patient with FLT3-ITD-positive AML
    Alkassis, Samer
    Rizwan, Aliza
    Daoud, Lina
    Chi, Jie
    BMJ CASE REPORTS, 2021, 14 (08)
  • [7] FLT3 inhibitors and hematopoietic cell transplantation prolong survival in patients with FLT3-ITD-positive AML
    Matsukawa, Toshihiro
    Onozawa, Masahiro
    Kondo, Takeshi
    Kanaya, Minoru
    Hidaka, Daisuke
    Ota, Shuichi
    Mori, Akio
    Shigematsu, Akio
    Miyagishima, Takuto
    Kakinoki, Yasutaka
    Hashiguchi, Junichi
    Yamamoto, Satoshi
    Yamamoto, Masayo
    Wakasa, Kentaro
    Takahata, Mutsumi
    Ishihara, Toshimichi
    Haseyama, Yoshihito
    Fujimi, Akihito
    Igarashi, Tetsuya
    Sarashina, Takehiro
    Iyama, Satoshi
    Kobayashi, Ryoji
    Sakai, Hajime
    Fujimoto, Katsuya
    Inamura, Junki
    Kanisawa, Yuji
    Hirabayashi, Shinsuke
    Endo, Tomoyuki
    Hashimoto, Daigo
    Teshima, Takanori
    ANNALS OF HEMATOLOGY, 2024, : 5333 - 5340
  • [8] Impact of CXCR4 inhibition on FLT3-ITD-positive human AML blasts
    Jacobi, Angela
    Thieme, Sebastian
    Lehmann, Romy
    Ugarte, Fernando
    Malech, Harry L.
    Koch, Sina
    Thiede, Christian
    Mueller, Katrin
    Bornhaeuser, Martin
    Ryser, Martin
    Brenner, Sebastian
    EXPERIMENTAL HEMATOLOGY, 2010, 38 (03) : 180 - 190
  • [9] NOX-driven ROS formation in cell transformation of FLT3-ITD-positive AML
    Jayavelu, Ashok Kumar
    Moloney, Jennifer N.
    Boehmer, Frank-D.
    Cotter, Thomas G.
    EXPERIMENTAL HEMATOLOGY, 2016, 44 (12) : 1113 - 1122
  • [10] Petromurin C Induces Protective Autophagy and Apoptosis in FLT3-ITD-Positive AML: Synergy with Gilteritinib
    Ha, You Na
    Song, Sungmi
    Orlikova-Boyer, Barbora
    Cerella, Claudia
    Christov, Christo
    Kijjoa, Anake
    Diederich, Marc
    MARINE DRUGS, 2020, 18 (01)
12345